A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1-7 (TXA-127) for the treatment of severe COVID-19.

ABSTRACT:

SUBMITTER: Wagener G 

PROVIDER: S-EPMC9332096 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature